Hilary Malone, PhD
Chief Operating Officer, Therapeutics
Hilary joined Valo in January 2020 as Chief Operating Officer, Therapeutics. Prior to Valo, Hilary was the Chief Regulatory Officer for Sanofi (a global life sciences company) for six years. In that role, Hilary led the global, regional and country-based regulatory organization supporting development, marketing, and manufacture across Sanofi’s global business of innovative prescription drugs in primary and specialty care, vaccines, generic drugs, and consumer health care.
Hilary is a recognized business leader with over 20 years of experience in drug research, development, and commercialization in the pharmaceutical industry, with a notable track record in ensuring products are brought to market, navigating development, regulatory, and market access hurdles to optimize revenue growth and profitability. Hilary has held senior executive and Board positions in both large publicly traded pharmaceutical companies and start-up biotech.
Trained as a Ph.D. in Neuropharmacology with academic experience, Hilary has significant board level and executive committee experience including large-scale organizational restructuring/transformation/integration, major M&A, capital raising, investor relations, and pre-IPO.